BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 640715)

  • 1. The reaction between the complement subcomponent C1q, IgG complexes and polyionic molecules.
    Hughes-Jones NC; Gardner B
    Immunology; 1978 Mar; 34(3):459-63. PubMed ID: 640715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional affinity constants of the reaction between 125I-labelled C1q and C1q binders and their use in the measurement of plasma C1q concentrations.
    Hughes-Jones NC
    Immunology; 1977 Feb; 32(2):191-8. PubMed ID: 844894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative analysis of the interaction between immune complex and C1q complement subcomponent. The role of interdomain interactions in rabbit IgG in binding of C1q to immune precipitates.
    Vonderviszt F; Török J; Lakatos S; Kilár F; Závodszky P
    Biochem J; 1987 Apr; 243(2):449-55. PubMed ID: 3498482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of C1q by monoclonal antibodies.
    Heinz HP; Loos M
    Behring Inst Mitt; 1984 Nov; (76):42-58. PubMed ID: 6335397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The binding site for C1q on IgG.
    Duncan AR; Winter G
    Nature; 1988 Apr; 332(6166):738-40. PubMed ID: 3258649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of the binding of C1q to immune complexes by polyethylene glycol.
    Wines BD; Easterbrook-Smith SB
    Mol Immunol; 1988 Mar; 25(3):263-6. PubMed ID: 3259672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of the first component of human complement, C1, by monoclonal antibodies directed against different domains of subcomponent C1q.
    Kilchherr E; Schumaker VN; Phillips ML; Curtiss LK
    J Immunol; 1986 Jul; 137(1):255-62. PubMed ID: 3486914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The complement subcomponent C1q mediates binding of immune complexes and aggregates to endothelial cells in vitro.
    Daha MR; Miltenburg AM; Hiemstra PS; Klar-Mohamad N; Van Es LA; Van Hinsbergh VW
    Eur J Immunol; 1988 May; 18(5):783-7. PubMed ID: 3259929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the interaction of the first complement component C1 and its subunit C1q with solid-phase IgM immune complexes.
    Weiner EM
    Scand J Immunol; 1988 Oct; 28(4):425-30. PubMed ID: 2461584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of soluble aggregates of IgG on the binding, uptake and degradation of the C1q subcomponent of complement by adherent guinea pig peritoneal macrophages.
    Veerhuis R; Van Es LA; Daha MR
    Eur J Immunol; 1985 Sep; 15(9):881-7. PubMed ID: 3876223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A solid-phase radioimmunoassay for C1q-binding immune complexes. I. Delta IgG as indicator molecule.
    Svehag SE
    Scand J Immunol; 1975; 4(7):687-97. PubMed ID: 1198070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of ionic strength, EDTA concentration, endogenous C1q and polyanions on the 125I-C1q-binding test.
    Hack CE; Huijbregts CC; Paardekooper J
    J Immunol Methods; 1984 Aug; 72(1):197-206. PubMed ID: 6205096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of direct binding of enzyme-conjugated antihuman IgG t C1q using dextran sulphate in solid phase assays for immune complexes.
    Gripenberg M; Rhen M; Hautanen A; Linder E
    J Clin Pathol; 1982 May; 35(5):581-2. PubMed ID: 6177719
    [No Abstract]   [Full Text] [Related]  

  • 14. C1Q, a subunit of the first component of complement, enhances the binding of aggregated IgG to rat renal mesangial cells.
    van den Dobbelsteen ME; van der Woude FJ; Schroeijers WE; Klar-Mohamad N; van Es LA; Daha MR
    J Immunol; 1993 Oct; 151(8):4315-24. PubMed ID: 8409404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship between the binding ability and the rate of activation of the complement component C1.
    Folkerd EJ; Gardner B; Hughes-Jones NC
    Immunology; 1980 Sep; 41(1):179-85. PubMed ID: 7429549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding of soluble immune complexes to Raji lymphocytes. Role of receptors for complement components, C1q and C3-C3b.
    Gupta RC; McDuffie FC; Tappeiner G; Jordon RE
    Immunology; 1978 Apr; 34(4):751-61. PubMed ID: 102587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative studies on biological activities of subcomponents C1q of the first component of human, bovine, mouse and guinea-pig complement.
    Sasaki T; Yonemasu K
    Biochim Biophys Acta; 1984 Mar; 785(3):118-22. PubMed ID: 6608375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal anti-mouse macrophage antibodies recognize the globular portions of C1q, a subcomponent of the first component of complement.
    Heinz HP; Dlugonska H; Rüde E; Loos M
    J Immunol; 1984 Jul; 133(1):400-4. PubMed ID: 6609989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of immune-complex size and antigen-antibody ratio on immune complex detection with monoclonal rheumatoid factor and C1q.
    Vanham G; Bloemmen FJ; Ceuppens JL; Stevens EA
    J Clin Lab Immunol; 1984 Oct; 15(2):63-8. PubMed ID: 6335179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating immune complexes in Lyme arthritis. Detection by the 125I-C1q binding, C1q solid phase, and Raji cell assays.
    Hardin JA; Walker LC; Steere AC; Trumble TC; Tung KS; Williams RC; Ruddy S; Malawista SE
    J Clin Invest; 1979 Mar; 63(3):468-77. PubMed ID: 429566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.